(19)
(11) EP 1 427 850 A2

(12)

(88) Date of publication A3:
19.06.2003

(43) Date of publication:
16.06.2004 Bulletin 2004/25

(21) Application number: 02757259.3

(22) Date of filing: 16.08.2002
(51) International Patent Classification (IPC)7C12Q 1/68, G06F 19/00, G01N 33/04, G01N 33/50, C07H 21/04, C07H 21/00, C12P 19/34, C12M 1/34
(86) International application number:
PCT/US2002/026514
(87) International publication number:
WO 2003/016500 (27.02.2003 Gazette 2003/09)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 16.08.2001 US 313080 P

(71) Applicant: Phase-1 Molecular Toxicology Inc.
Santa Fe, NM 87505 (US)

(72) Inventors:
  • NEFT, Robin, E.
    Albuquerque, NM 87123 (US)
  • DUNN, Robert, T., II
    Rio Rancho, NM 87124 (US)
  • ADKINS, Karissa
    Champlin, MN 55316 (US)
  • PICKETT, Gavin, G.
    Albuquerque, NM 87111 (US)
  • KIER, Larry, D.
    Santa Fe, NM 87507 (US)
  • SCHMEISER, Katja
    B-9830 Sint Martens Latem (BE)
  • ALEN, Phillippe
    B-1702 Groot Byagaarden (BE)

(74) Representative: Mohnhaupt, Dietrich et al
IPTO S.A.,P.O. Box 594
3000 Bern 25
3000 Bern 25 (CH)

   


(54) HUMAN TOXICOLOGICALLY RELEVANT GENES AND ARRAYS